SEC Form 4 · accession 0001144204-18-012331
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2018 | Z | 42,447,810 | $0.00 | D | 42,447,810 | I | By Trust |
| Common StockF1 | Feb 27, 2018 | Z | 31,982 | $0.00 | D | 31,982 | I | By Trust |
| Common StockF1 | Feb 27, 2018 | Z | 56,288 | $0.00 | D | 56,288 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Effective as of February 27, 2018, Dr. John N. Kapoor ("Dr. Kapoor"), personally and as trustee of John N. Kapoor Trust, dated September 20, 1989, entered into a voting trust agreement (the "Voting Trust Agreement") by and among Insys Therapeutics, Inc., a Delaware corporation (the "Company"), Dr. Kapoor, Bessemer Trust Company of Delaware, N.A., as the initial trustee thereunder (the "Trustee") and EJ Financial/NEO Management, L.P., pursuant to which the parties have established a voting trust (within the meaning of Section 218(a) of the Delaware General Corporation Law) (the "Voting Trust"). With the formation of the Voting Trust, the shares of the Company's common stock, par value $0.01 per share, beneficially owned by Dr. Kapoor and EJ Financial/NEO Management, L.P. were deposited with the Trustee. Dr. Kapoor is an affiliate of EJ Financial/NEO Management, L.P.